-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In order to implement the spirit of the important instructions and instructions of General Secretary Jin Ping on children's medication, in-depth implementation of "I do practical things for the masses" practical activities, and strive to solve the problem of children's medication shortage
.
On September 24, the Center for Drug Evaluation held an expert seminar on hot topics in children’s drug R&D, inviting pediatric clinical research institutions and domestic and foreign companies dedicated to children’s drug R&D to discuss the application of the "joint work model" in the children’s drug industry.
Kong Fanpu pointed out that after the previous stage of exploration and practice, the work model of joint production, study, research, and review around children's drug use has taken shape, and multiple links have achieved results or are in progress
.
For example, the three special guidelines for children’s medications released this year are jointly completed by R&D companies, research units, and regulatory agencies.
In the discussion session, the participants discussed the problems and solutions in the research and development of children's medicines in China
.
Ni Xin, Dean of the National Children’s Medical Center (Beijing Children’s Hospital), made a speech on behalf of pediatric clinical research institutions.
This meeting is a phased summary meeting for the Drug Evaluation Center to implement the important decisions and deployments of the Party Central Committee, and to promote the development and innovation of children’s drugs.
Members of the Special Working Group on Children's Drug Use of the Center for Drug Evaluation attended the meeting
